Does TEZEPELUMAB Cause Interstitial lung disease? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with TEZEPELUMAB (TEZSPIRE). This represents 0.5% of all adverse event reports for TEZEPELUMAB.
6
Reports of Interstitial lung disease with TEZEPELUMAB
0.5%
of all TEZEPELUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Interstitial lung disease From TEZEPELUMAB?
Of the 6 reports, 2 (33.3%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEZEPELUMAB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TEZEPELUMAB Cause?
Asthma (204)
Dyspnoea (170)
Pneumonia (140)
Death (92)
Cough (87)
Wheezing (83)
Drug ineffective (81)
Fall (47)
Fatigue (47)
Arthralgia (41)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TEZEPELUMAB Alternatives Have Lower Interstitial lung disease Risk?
TEZEPELUMAB vs TEZEPELUMAB-EKKO
TEZEPELUMAB vs THALIDOMIDE
TEZEPELUMAB vs THALOMID
TEZEPELUMAB vs THEOPHYLLINE
TEZEPELUMAB vs THEOPHYLLINE ANHYDROUS